$ cat ./records/gates-foundation-awards-46-million-to-marie-stopes-international--2012.txt
Gates Foundation Awards $46 Million to Marie Stopes International for Reproductive Health
[RECORD.TXT] · cat --full
The Gates Foundation provided $46.1 million to Marie Stopes International (now MSI Reproductive Choices) as part of the London Summit on Family Planning commitments. Marie Stopes is one of the world's largest providers of voluntary contraceptive and reproductive health services, operating clinics and community outreach in 37 countries. Subsequent Gates-funded collaboration with Global Affairs Canada supported MSI's Smart Start programme, reaching 48 rural districts in Ethiopia with family planning outreach teams and expanding access to implants, IUDs, and injectable contraceptives for women who had never previously accessed formal health services.
Source: https://www.gatesfoundation.org/about/committed-grants/2014/11/inv-008473
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Commits $363 Million at London Declaration on Neglected Tropical Diseases to Eliminate 10 NTDs by 2020
Next →
Gates Foundation Organises FP2020 Partnership Targeting Contraceptive Access for 120 Million Women
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.